235 related articles for article (PubMed ID: 36778205)
21. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.
Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y
Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781
[TBL] [Abstract][Full Text] [Related]
23. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes.
Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H
World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452
[TBL] [Abstract][Full Text] [Related]
24. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer.
Wu P; Shi J; Sun W; Zhang H
Cancer Cell Int; 2021 Oct; 21(1):523. PubMed ID: 34627252
[TBL] [Abstract][Full Text] [Related]
26. A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma.
Li Y; Li Y; Zhang X; Duan X; Feng H; Yu Z; Gao Y
Front Oncol; 2022; 12():986827. PubMed ID: 36267972
[TBL] [Abstract][Full Text] [Related]
27. The study of an anoikis-related signature to predict glioma prognosis and immune infiltration.
Zhang D; Wang Y; Zhou H; Han X; Hou L; Lv Z; Xue X
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12659-12676. PubMed ID: 37450027
[TBL] [Abstract][Full Text] [Related]
28. Identification of a pyroptosis-related prognosis gene signature and its relationship with an immune microenvironment in gliomas.
Xiao S; Yan Z; Zeng F; Lu Y; Qiu J; Zhu X
Medicine (Baltimore); 2022 Jul; 101(28):e29391. PubMed ID: 35839032
[TBL] [Abstract][Full Text] [Related]
29. Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes.
Li J; Wang S; Chi X; He Q; Tao C; Ding Y; Wang J; Zhao J; Wang W
Front Immunol; 2023; 14():1183475. PubMed ID: 37334354
[TBL] [Abstract][Full Text] [Related]
30. A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma.
Wang H; Yan L; Liu L; Lu X; Chen Y; Zhang Q; Chen M; Cai L; Dai Z
PeerJ; 2023; 11():e16412. PubMed ID: 38025749
[TBL] [Abstract][Full Text] [Related]
31. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
Huang Q; Li J; Mo L; Zhao Y
World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
[TBL] [Abstract][Full Text] [Related]
32. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
[TBL] [Abstract][Full Text] [Related]
33. Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer.
Zhang X; Liang H; Tang Q; Chen H; Guo F
Front Genet; 2022; 13():801665. PubMed ID: 35846123
[TBL] [Abstract][Full Text] [Related]
34. Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma.
Liu H; Tao T
Front Oncol; 2022; 12():1015850. PubMed ID: 36605437
[TBL] [Abstract][Full Text] [Related]
35. Predicting the prognosis in patients with sepsis by a pyroptosis-related gene signature.
Liang S; Xing M; Chen X; Peng J; Song Z; Zou W
Front Immunol; 2022; 13():1110602. PubMed ID: 36618365
[TBL] [Abstract][Full Text] [Related]
36. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
37. A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma.
Wu C; Zhao J; Wang X; Wang Y; Zhang W; Zhu G
Transl Cancer Res; 2022 Aug; 11(8):2647-2659. PubMed ID: 36093538
[TBL] [Abstract][Full Text] [Related]
38. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
Xiang Z; Chen X; Lv Q; Peng X
Front Genet; 2021; 12():697819. PubMed ID: 34408772
[TBL] [Abstract][Full Text] [Related]
39. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
Wu Y; Peng Z; Gu S; Wang H; Xiang W
Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
[TBL] [Abstract][Full Text] [Related]
40. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors.
Lai G; Li K; Deng J; Liu H; Xie B; Zhong X
J Healthc Eng; 2022; 2022():8704127. PubMed ID: 35535221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
